NASD Insider Trading Activity and SEC Form 4 Filings
NASD insider trading summary
No open-market insider purchases or sales of Abiomed Inc (NASD) have been reported on SEC Form 4 in the past 12 months.
Latest NASD insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Nov 16, 2022 | Martin P Sutter | Insider | Sell | $696K (1,859 @ $374.66) |
| Nov 16, 2022 | Martin P Sutter | Insider | Sell | $53K (141 @ $375.56) |
| Nov 15, 2022 | Martin P Sutter | Insider | Sell | $424K (1,133 @ $374.18) |
| Nov 15, 2022 | Martin P Sutter | Insider | Sell | $325K (867 @ $374.92) |
| Nov 4, 2022 | Marc A Began | VP & General Counsel | Sell | $747K (2,000 @ $373.71) |
| Nov 1, 2022 | Matthew T. Plano | VP, Global Operations | Sell | $57K (149 @ $380.22) |
| Nov 1, 2022 | Matthew T. Plano | VP, Global Operations | Sell | $274K (722 @ $379.33) |
| Nov 1, 2022 | Matthew T. Plano | VP, Global Operations | Sell | $643K (1,699 @ $378.61) |
| Nov 1, 2022 | Todd A Trapp | Vice President, CFO | Sell | $25K (67 @ $380.20) |
| Nov 1, 2022 | Todd A Trapp | Vice President, CFO | Sell | $181K (479 @ $378.64) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.